Praram 9 Hospital PCL (BKK:PR9)
Thailand
· Delayed Price · Currency is THB 17.30
0.00 (0.00%)
At close: Mar 6, 2026
Praram 9 Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 5,292 | 4,649 | 4,216 | 4,122 | 3,000 | Upgrade
|
| Other Revenue | 49.14 | 41.51 | 36.86 | 28.16 | 26.12 | Upgrade
|
| Revenue | 5,341 | 4,691 | 4,253 | 4,150 | 3,026 | Upgrade
|
| Revenue Growth (YoY) | 13.88% | 10.29% | 2.47% | 37.16% | 14.93% | Upgrade
|
| Cost of Revenue | 3,346 | 3,045 | 2,820 | 2,724 | 2,172 | Upgrade
|
| Gross Profit | 1,995 | 1,645 | 1,433 | 1,427 | 853.75 | Upgrade
|
| Selling, General & Admin | 1,032 | 837.22 | 773.68 | 735.1 | 557.21 | Upgrade
|
| Operating Expenses | 1,032 | 837.22 | 773.68 | 735.1 | 557.21 | Upgrade
|
| Operating Income | 962.67 | 807.89 | 659.09 | 691.81 | 296.53 | Upgrade
|
| Interest Expense | -0.76 | -0.49 | -0.64 | -0.48 | -0.48 | Upgrade
|
| Interest & Investment Income | 51.32 | 54.62 | 30.17 | 8.72 | 4.21 | Upgrade
|
| Pretax Income | 1,013 | 862.01 | 688.63 | 700.05 | 300.27 | Upgrade
|
| Income Tax Expense | 190.51 | 149.33 | 130.77 | 132.44 | 51.1 | Upgrade
|
| Net Income | 822.71 | 712.68 | 557.86 | 567.61 | 249.17 | Upgrade
|
| Net Income to Common | 822.71 | 712.68 | 557.86 | 567.61 | 249.17 | Upgrade
|
| Net Income Growth | 15.44% | 27.75% | -1.72% | 127.80% | 23.32% | Upgrade
|
| Shares Outstanding (Basic) | 786 | 786 | 786 | 786 | 786 | Upgrade
|
| Shares Outstanding (Diluted) | 786 | 786 | 786 | 786 | 786 | Upgrade
|
| EPS (Basic) | 1.05 | 0.91 | 0.71 | 0.72 | 0.32 | Upgrade
|
| EPS (Diluted) | 1.05 | 0.91 | 0.71 | 0.72 | 0.32 | Upgrade
|
| EPS Growth | 15.44% | 27.75% | -1.72% | 127.80% | 23.32% | Upgrade
|
| Free Cash Flow | 495.95 | 804.87 | 514.74 | 736.32 | 344.49 | Upgrade
|
| Free Cash Flow Per Share | 0.63 | 1.02 | 0.66 | 0.94 | 0.44 | Upgrade
|
| Dividend Per Share | 0.500 | 0.400 | 0.300 | 0.290 | 0.140 | Upgrade
|
| Dividend Growth | 25.00% | 33.33% | 3.45% | 107.14% | 27.27% | Upgrade
|
| Gross Margin | 37.35% | 35.07% | 33.69% | 34.38% | 28.21% | Upgrade
|
| Operating Margin | 18.02% | 17.22% | 15.50% | 16.67% | 9.80% | Upgrade
|
| Profit Margin | 15.40% | 15.19% | 13.12% | 13.68% | 8.23% | Upgrade
|
| Free Cash Flow Margin | 9.29% | 17.16% | 12.10% | 17.74% | 11.39% | Upgrade
|
| EBITDA | 1,263 | 1,097 | 941.45 | 974.8 | 570.13 | Upgrade
|
| EBITDA Margin | 23.65% | 23.39% | 22.14% | 23.49% | 18.84% | Upgrade
|
| D&A For EBITDA | 300.57 | 289.25 | 282.35 | 282.98 | 273.6 | Upgrade
|
| EBIT | 962.67 | 807.89 | 659.09 | 691.81 | 296.53 | Upgrade
|
| EBIT Margin | 18.02% | 17.22% | 15.50% | 16.67% | 9.80% | Upgrade
|
| Effective Tax Rate | 18.80% | 17.32% | 18.99% | 18.92% | 17.02% | Upgrade
|
| Revenue as Reported | 5,341 | 4,691 | 4,253 | 4,150 | 3,026 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.